Blood Cancer News
Most blood cancers, conjointly known as haematological cancers, begin within the bone marrow, that is wherever blood is created. Blood cancers occur once abnormal blood
cells begin growing out of management, interrupting the operate of traditional blood cells, that fight
infection and manufacture new blood cells, The 3 main varieties of blood
cancer square measure leukaemia, malignant neoplastic disease and myeloma:
Leukemia may be a blood
cancer that originates within the blood and bone marrow. It happens once the body creates too several abnormal white blood
cells and interferes with the bone marrow’s ability to form red blood
cells and platelets.
Non-Hodgkin malignant neoplastic disease may be a blood
cancer that develops within the vascular system from
cells known as lymphocytes, a sort of white blood corpuscle that helps the body fight infections.
Hodgkin malignant neoplastic disease may be a blood
cancer that develops within the vascular system from
cells known as lymphocytes. Hodgkin malignant neoplastic disease is characterised by the presence of Associate in
Nursing abnormal white blood cell known as the Reed-Sternberg cell.
Multiple myeloma may be a blood
cancer that begins within the blood’s plasma cells, a sort of white blood corpuscle created within the bone marrow.
High Impact List of Articles
-
Diabetologist's core competence curriculum: A position statement of the amd (Italian association of medical diabetologists)
N. Musacchio*, R. Candidom, A. Cimino, A. De Micheli, A. Giancaterini, L. Monge, A. Ozzello, M.A. Pellegrini, M.C. Ponziani, M. Ragonese, S De Cosmo, G.T. Russo, C. Suraci, R. Zilich
Research Article: Diabetes Management
-
Diabetologist's core competence curriculum: A position statement of the amd (Italian association of medical diabetologists)
N. Musacchio*, R. Candidom, A. Cimino, A. De Micheli, A. Giancaterini, L. Monge, A. Ozzello, M.A. Pellegrini, M.C. Ponziani, M. Ragonese, S De Cosmo, G.T. Russo, C. Suraci, R. Zilich
Research Article: Diabetes Management
-
A physician-patient’s perspective on lowering glycemic variability – Part I: The role of meal timing
Elsamma Chacko* & Christine Signore
Case Report: Diabetes Management
-
A physician-patient’s perspective on lowering glycemic variability – Part I: The role of meal timing
Elsamma Chacko* & Christine Signore
Case Report: Diabetes Management
-
Diabetic Kidney Disease: A stepwise approach to combat disease
Yusra Habib Khan* & Tauqeer Hussain Mallhi
Editorial: Diabetes Management
-
Diabetic Kidney Disease: A stepwise approach to combat disease
Yusra Habib Khan* & Tauqeer Hussain Mallhi
Editorial: Diabetes Management
-
Th17 cells in Type 1 diabetes: a future perspective
Laura A Solt & Thomas P Burris
Editorial: Diabetes Management
-
Th17 cells in Type 1 diabetes: a future perspective
Laura A Solt & Thomas P Burris
Editorial: Diabetes Management
-
Managing inflammatory diabetic neuropathies
Jennifer A Tracy & P James B Dyck
Review Article: Diabetes Management
-
Managing inflammatory diabetic neuropathies
Jennifer A Tracy & P James B Dyck
Review Article: Diabetes Management
-
Screening for diabetes: what do the results of the ADDITION trial mean for clinical practice?
Torsten Lauritzen, Knut Borch-Johnsen, Melanie J Davies, Kamlesh Khunti, Guy EHM Rutten, Annelli Sandbak, Rebecca K Simmons, Maureen van den Donk, Nicholas J Wareham & Simon J Griffin
Management Perspectives: Diabetes Management
-
Screening for diabetes: what do the results of the ADDITION trial mean for clinical practice?
Torsten Lauritzen, Knut Borch-Johnsen, Melanie J Davies, Kamlesh Khunti, Guy EHM Rutten, Annelli Sandbak, Rebecca K Simmons, Maureen van den Donk, Nicholas J Wareham & Simon J Griffin
Management Perspectives: Diabetes Management
Relevant Topics in Clinical